Search

everythinglearnresearchcommunity

for

Search:↓

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Scalp medⓇ effectively and safely improves hair growth in men with androgenetic alopecia.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Injectable platelet-rich fibrin with microneedling is safe and effective for male hair loss but less supported than other treatments.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Tridax procumbens parts have antioxidant properties.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Dutasteride more effective than finasteride for hair growth; SM04554 safe and potentially effective for hair loss.

A reliable method was created to measure dutasteride and related molecules in capsules.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Monilethrix is a genetic hair disorder affecting hair shape, seen in two brothers.

Chloroquine and cinchonine relax rat blood vessels by affecting calcium channels, with chloroquine needing caution in heart patients.

Pill splitting increased generic finasteride sales but didn't affect branded finasteride sales.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Scalp med(R) effectively and safely improves hair count and thickness in men with androgenetic alopecia.

The new fluoroquinolone effectively fights certain bacteria.

Combining minoxidil with microneedling or spironolactone is more effective for female hair loss than using minoxidil alone.

A new compound effectively inhibits human 5α-reductase 1.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

The treatment is safe and shows promise for metastatic breast cancer.

CA-SLN-Ngel significantly reduces cellulite more effectively than regular caffeine gel.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Using dutasteride during hair transplants improves results and reduces hair loss.